224 related articles for article (PubMed ID: 36184307)
1. Universal chimeric antigen receptor T cell therapy - The future of cell therapy: A review providing clinical evidence.
Sun W; Jiang Z; Jiang W; Yang R
Cancer Treat Res Commun; 2022; 33():100638. PubMed ID: 36184307
[TBL] [Abstract][Full Text] [Related]
2. Charting new paradigms for CAR-T cell therapy beyond current Achilles heels.
Li Y; Hu Z; Li Y; Wu X
Front Immunol; 2024; 15():1409021. PubMed ID: 38751430
[TBL] [Abstract][Full Text] [Related]
3. Application of Chimeric Antigen Receptor T Cells in the Treatment of Hematological Malignancies.
Yan W; Liu Z; Liu J; Xia Y; Hu K; Yu J
Biomed Res Int; 2020; 2020():4241864. PubMed ID: 33062678
[TBL] [Abstract][Full Text] [Related]
4. Expanding the role of CAR T-cell therapy: From B-cell hematological malignancies to autoimmune rheumatic diseases.
Shumnalieva R; Velikova T; Monov S
Int J Rheum Dis; 2024 May; 27(5):e15182. PubMed ID: 38742463
[TBL] [Abstract][Full Text] [Related]
5. Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope?
Zhang PF; Xie D
Front Immunol; 2024; 15():1362133. PubMed ID: 38558812
[TBL] [Abstract][Full Text] [Related]
6. Emerging Strategies to Overcome Current CAR-T Therapy Dilemmas - Exosomes Derived from CAR-T Cells.
Hu D; Yang R; Wang G; Li H; Fan X; Liang G
Int J Nanomedicine; 2024; 19():2773-2791. PubMed ID: 38525009
[TBL] [Abstract][Full Text] [Related]
7. Clinical Pharmacology Considerations for the "Off-the-Shelf" Allogeneic Cell Therapies.
Mody H; Sutaria DS; Miles D
Clin Pharmacol Ther; 2024 Jun; 115(6):1233-1250. PubMed ID: 38501153
[TBL] [Abstract][Full Text] [Related]
8. Recent advances on CAR-T signaling pave the way for prolonged persistence and new modalities in clinic.
Smirnov S; Mateikovich P; Samochernykh K; Shlyakhto E
Front Immunol; 2024; 15():1335424. PubMed ID: 38455066
[TBL] [Abstract][Full Text] [Related]
9. Toxicities, intensive care management, and outcome of chimeric antigen receptor T cells in adults: an update.
Bellal M; Malherbe J; Damaj G; Du Cheyron D
Crit Care; 2024 Mar; 28(1):69. PubMed ID: 38444031
[TBL] [Abstract][Full Text] [Related]
10. Current status and future challenges of CAR-T cell therapy for osteosarcoma.
Li S; Zhang H; Shang G
Front Immunol; 2023; 14():1290762. PubMed ID: 38187386
[TBL] [Abstract][Full Text] [Related]
11. Expanding the horizon of transient CAR T therapeutics using virus-free technology.
Enriquez-Rodriguez L; Attia N; Gallego I; Mashal M; Maldonado I; Puras G; Pedraz JL
Biotechnol Adv; 2024; 72():108350. PubMed ID: 38537878
[TBL] [Abstract][Full Text] [Related]
12. Emerging Biomarkers for Monitoring Chimeric Antigen Receptor T-Cell Therapy.
Mamo T; Dreyzin A; Stroncek D; McKenna DH
Clin Chem; 2024 Jan; 70(1):116-127. PubMed ID: 38175598
[TBL] [Abstract][Full Text] [Related]
13. CAR T treatment beyond cancer: Hope for immunomodulatory therapy of non-cancerous diseases.
Yang Z; Liu Y; Zhao H
Life Sci; 2024 May; 344():122556. PubMed ID: 38471620
[TBL] [Abstract][Full Text] [Related]
14. How I approach optimization of patients at risk of cardiac and pulmonary complications after CAR T-cell therapy.
Gutierrez C; Neilan TG; Grover NS
Blood; 2023 May; 141(20):2452-2459. PubMed ID: 36827628
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives.
Levstek L; Janžič L; Ihan A; Kopitar AN
Front Immunol; 2024; 15():1378944. PubMed ID: 38558801
[TBL] [Abstract][Full Text] [Related]
16. An IQ Consortium Perspective on Best Practices for Bioanalytical and Immunogenicity Assessment Aspects of CAR-T and TCR-T Cellular Therapies Development.
Gokemeijer J; Balasubramanian N; Ogasawara K; Grudzinska-Goebel J; Upreti VV; Mody H; Kasar S; Vepachedu VR; Xu W; Gupta S; Tarcsa E; Dodge R; Herr K; Yang TY; Tourdot S; Jawa V
Clin Pharmacol Ther; 2024 Feb; 115(2):188-200. PubMed ID: 37983584
[TBL] [Abstract][Full Text] [Related]
17. Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy.
Dhawale T; Johnson PC; Boateng K; Barata A; Traeger L; Nelson AM; Lavoie MW; Holmbeck K; Choe J; Nabily A; Tripathi A; Amonoo HL; Frigault M; El-Jawahri A
Transplant Cell Ther; 2024 Apr; 30(4):402.e1-402.e12. PubMed ID: 38262530
[TBL] [Abstract][Full Text] [Related]
18. Manufacturing Cell and Gene Therapies: Challenges in Clinical Translation.
Lee NK; Chang JW
Ann Lab Med; 2024 Jul; 44(4):314-323. PubMed ID: 38361427
[TBL] [Abstract][Full Text] [Related]
19. CAR-T cell therapeutic avenue for fighting cardiac fibrosis: Roadblocks and perspectives.
Abdalla AME; Miao Y; Ahmed AIM; Meng N; Ouyang C
Cell Biochem Funct; 2024 Mar; 42(2):e3955. PubMed ID: 38379220
[TBL] [Abstract][Full Text] [Related]
20. [CAR-T therapy for autoimmune diseases].
Alcaraz-Serna A; Porret R; Trueb L; Ribi C; Seebach J; Muller YD
Rev Med Suisse; 2024 Apr; 20(868):688-693. PubMed ID: 38568061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
